Immune System Diseases

The department investigates innovative therapies for immune system diseases, with a strong emphasis on conditions such as rheumatoid arthritis and psoriatic arthritis, aiming to improve joint function and patient quality of life.

  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • ACPA-Positive Rheumatoid Arthritis

Ongoing work includes evaluating biologic agents, biosimilars, and novel small‑molecule inhibitors to achieve better disease control and reduced long‑term complications.

Musculoskeletal Diseases

Research at the site targets musculoskeletal diseases, focusing on degenerative joint disorders and bone health, including knee osteoarthritis and osteoporosis, to alleviate pain and preserve mobility.

  • Knee Osteoarthritis
  • Osteoporosis
  • Chronic Pain from Osteoarthritis

Studies explore weight‑management strategies, analgesic options, and disease‑modifying treatments that can slow progression and enhance daily functioning.

Nutritional and Metabolic Diseases

The clinic’s portfolio includes trials on nutritional and metabolic diseases, particularly addressing metabolic imbalances such as hyperuricemia associated with gout and excess body weight, with the goal of normalizing biochemical markers and supporting healthy lifestyles.

  • Gout‑Associated Hyperuricemia
  • Overweight and Obesity

Investigations evaluate uric‑acid‑lowering agents and weight‑reduction interventions that may also lessen joint stress and cardiovascular risk.

Respiratory Tract Diseases

Clinical activity also covers respiratory tract diseases, with a focus on patients suffering from moderate‑to‑severe chronic obstructive pulmonary disease, seeking therapies that reduce flare‑ups and improve lung function.

  • Moderate-to-Severe COPD

Trials assess novel inhaled compounds and systemic agents designed to decrease exacerbation frequency and enhance overall respiratory health.

Skin and Connective Tissue Diseases

The department conducts extensive research on skin and connective tissue diseases, including conditions such as plaque psoriasis, atopic dermatitis, palmoplantar pustulosis, and vitiligo, aiming to provide better symptom control and skin restoration.

  • Plaque Psoriasis
  • Atopic Dermatitis
  • Palmoplantar Pustulosis
  • Vitiligo

Research evaluates emerging immunomodulators, targeted biologics, and topical formulations to achieve clearer skin and durable remission.